RT Journal Article
SR Electronic
T1 Cancer as a novel Risk Factor for Major Adverse Cardiovascular Events in Secondary Prevention
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.16.24310536
DO 10.1101/2024.07.16.24310536
A1 Melchiori, Renzo
A1 Diaz Saravia, Sara
A1 Rubio, Pablo
A1 Szlaien, Lucas
A1 Mouriño, Romina
A1 O’Flaherty, Martin
A1 Rizzo, Miguel
A1 Hita, Alejandro
YR 2024
UL http://medrxiv.org/content/early/2024/07/17/2024.07.16.24310536.abstract
AB Introduction The inflammatory mechanisms of cancer can be associated with atherosclerosis development and progression. Although there is an incidence rate of cardiovascular events in secondary prevention following a first acute coronary syndrome (ACS).Methods A retrospective study cohort study including patients who underwent a PCI for first Acute Coronary Syndrome (ACS), and without prior history of Major Cardiovascular Events (MACE) from 2008 to 2022 was analyzed. Included patients were grouped according to the absence or presence of cancer: G1 non-oncologic, and G2 oncologic (either prior or actual history). We compared the incidence rate ratio of MACE within 3 years after STEMI between groups Time-to-event analysis was conducted through proportional Cox regression analysis, estimating hazard ratio, and corresponding 95% confidence intervals (95% CI)Results Out of 937 patients who underwent a PCI, 787 patients were included of which 88.7% (n=698) presented without cancer. Over a median follow-up time of 45 months [IQR= 14-72], the incidence rate of MACE was 4.4 cases per 1000 patients/months of follow-up (n=173 MACE events). When comparing both groups, the incidence rate ratio of MACE was 1.9 (95% CI 1.24-2.99), significantly increased in the cancer group (P=0.0032) without showing differences in median follow-up times. Cancer was an independent predictor of MACE HR 1.84 (95% CI 1.19-2.85; P=0.006), adjusted for hypertension, dyslipidemia, diabetes, smoking history, sedentary lifestyle, obesity, age, male gender, and family history of cardiovascular disease.Conclusions Patients with cancer represent a novel independent risk factor for MACE, even following secondary preventive therapies. These results highlight future endpoints for cardiovascular prevention and further public health interventions on this population.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot Applicable (not a clinical trial)Funding StatementNo funding was received or requested for design, data collection, data analysis, writing process, and publication of this scientific work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was submitted and approved by our Institutional Review Board (Institutional Evaluation Committee of the Universidad Austral, CIE No. P21-022)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll data was collected from electronic medical records from our university hospital, and was stored in a confidential manner. This data is kept safe by the corresponding author and can be make available for review upon request.